Citation: Js. Sergent, PLAINTIFFS, DEFENDANTS, LAWYERS, AND LAWYERS - FACTS AND RUMORS ABOUTSILICONE, Western journal of medicine, 167(3), 1997, pp. 182-183
Citation: Vm. Byrd et Js. Sergent, SUPPRESSION OF SYSTEMIC LUPUS-ERYTHEMATOSUS BY THE HUMAN-IMMUNODEFICIENCY-VIRUS, Journal of rheumatology, 23(7), 1996, pp. 1295-1296
Citation: H. Fuchs et al., STILL MORE ON BREAST IMPLANTS AND CONNECTIVE-TISSUE DISEASES, The New England journal of medicine, 333(8), 1995, pp. 526-526
Citation: J. Sanchezguerrero et al., RHEUMATIC DISEASE SYMPTOMS AND SILICONE BREAST IMPLANTS - REPLY, Arthritis and rheumatism, 38(5), 1995, pp. 721-721
Citation: Js. Sergent, INTRAARTICULAR TREATMENT OF OSTEOARTHRITIS AND GUIDELINES TO ITS ASSESSMENT - COMMENT, Journal of rheumatology, 21, 1994, pp. 76-76
Citation: Cw. Legerton et al., RENAL COAGULOPATHY, THROMBOCYTOPENIA, AND THE ANTICARDIOLIPIN ANTIBODY - THERAPEUTIC RESPONSE TO CORTICOSTEROIDS AND ASPIRIN BUT NOT ANTICOAGULATION, Journal of rheumatology, 21(1), 1994, pp. 172-172
Citation: J. Sanchezguerrero et al., SILICONE BREAST IMPLANTS AND RHEUMATIC DISEASE - CLINICAL, IMMUNOLOGICAL, AND EPIDEMIOLOGIC STUDIES, Arthritis and rheumatism, 37(2), 1994, pp. 158-168
Citation: Js. Sergent et Rs. Panush, CONTROVERSIES IN CLINICAL RHEUMATOLOGY - PREFACE, Rheumatic diseases clinics of North America, 19(1), 1993, pp. 15-15